Quest Diagnostics Inc (DGX) Shareholders’ equity 2016–2025
Quest Diagnostics Inc (DGX) shareholders’ equity at each fiscal year-end, per SEC filings.
$7.2BFY2025 · since FY2016: $4.6B → $7.2B
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $7.2B | +5.8% |
| FY2024 | $6.8B | +7.5% |
| FY2023 | $6.3B | +7.0% |
| FY2022 | $5.9B | -8.6% |
| FY2021 | $6.4B | -4.7% |
| FY2020 | $6.8B | +19.8% |
| FY2019 | $5.6B | +8.1% |
| FY2018 | $5.2B | +6.0% |
| FY2017 | $4.9B | +6.3% |
| FY2016 | $4.6B | — |
Source: SEC XBRL filings · For reference only · Not investment advice